INC Research moves HQ to bring about growth
“This move better positions us to accommodate future growth of our clinical trials outsourcing services,” said INC Research CEO, James Ogle.
INC’s Corporate Learning Centre, which focuses on internal training and certification programs in project management and therapeutic clinical research, will be set up within the 120,000sq ft space between the firm’s new location at 3201 Beechleaf Court in Raleigh, US, and its existing office at 4800 Falls of Neuse Road.
The CRO’s Project Solutions Lab which provides simulation training for staff will also be housed at the new plot. INC said it has sealed a multi-year deal to occupy the area to accommodate current work being carried out and to allow future growth for the business.
“This is an exciting stage in the history of INC Research,” said Ogle, who explained: “We have continued to enhance and expand our global drug development capabilities based on consumer demand.”
Over the last year, the firm launched its Alliance Partnership division which is responsible for creating and managing clinical delivery collaborations with pharma and biotechnology customers.
Global management team expansion
With an eye to expanding clinical trial research operations across the globe and to strengthen its presence in emerging markets, INC expanded its global medical management team in September with the addition of three new medical directors in Buenos Aires in Argentina, China’s capital of Beijing and Gurgaon in India.
Clinical trials business acquisition
Furthermore, the company acquired MDS Pharma Services’ later-phase clinical trials business in 2009 in a $50m deal which covers the Phase II, III and IV clinical operations of MDS Pharma.
The acquisition was made as INC had planned to expand its footprint in international markets, including South America, Asia and Africa.
INC now employs over 2000 research staff and conducts clinical trials in more than 40 countries around the world.
